{
    "q": [
        {
            "docid": "12999450_24",
            "document": "History of emerging infectious diseases . \"Blastocystis\" is a single-celled protozoan which infects the large intestine. Physicians report that patients with infection show symptoms of abdominal pain, constipation, and diarrhea. One study found that 43% of IBS patients were infected with \"Blastocystis\" versus 7% of controls. An additional study found that many IBS patients from whom \"Blastocystis\" could not be identified showed a strong antibody reaction to the organism, which is a type of test used to diagnose certain difficult-to-detect infections. Other researchers have also reported that special testing techniques may be necessary to identify the infection in some people. While some scientists believe the finding that IBS patients carry a protozoal infection to be significant, other researchers have reported their belief that the presence of the infection is not medically significant. Researchers report that the infection can be resistant to common protozoal treatments in laboratory culture study, and in experience with patients,; therefore, identifying \"Blastocystis\" infection may not be of immediate help to a patient. A 2006 study of gastrointestinal infections in the United States suggested that \"Blastocystis\" infection has become the leading cause of protozoal diarrhea in that country. \"Blastocystis\" was the most frequently identified protozoal infection found in patients in a 2006 Canadian study.",
            "score": 75.80426287651062
        },
        {
            "docid": "30321101_8",
            "document": "Transmission-based precautions . Since the infecting agent often is not known at the time of admission to a healthcare facility, transmission-based precautions are used empirically, according to the clinical syndrome and the likely etiologic agents at the time, and then modified when the pathogen is identified or a transmissible infectious etiology is ruled out. Diagnosis of many infections requires laboratory confirmation. Since laboratory tests, especially those that depend on culture techniques, often require two or more days for completion, transmission-based precautions must be implemented while test results are pending based on the clinical presentation and likely pathogens. Use of appropriate transmission-based precautions at the time a patient develops symptoms or signs of transmissible infection, or arrives at a healthcare facility for care, reduces transmission opportunities. While it is not possible to identify prospectively all patients needing transmission-based precautions, certain clinical syndromes and conditions carry a sufficiently high risk to warrant their use empirically while confirmatory tests are pending. \u00b9 Patients with the syndromes or conditions listed below may present with atypical signs or symptoms (e.g.neonates and adults with pertussis may not have paroxysmal or severe cough). The clinician's index of suspicion should be guided by the prevalence of specific conditions in the community, as well as clinical judgment.",
            "score": 77.23999357223511
        },
        {
            "docid": "56598639_8",
            "document": "Innate immune defect . Patients with innate immune defects have generally intact adaptive immune systems with normal antibodies and T-cells. The main symptom is increased level of eosinophils in the blood, but elevated immunoglobulin E (IgE) levels may also be present. The diagnosis is made in suspected patients by measuring cytokine production by white blood cells, after stimulation by bacterial products. Testing of TLR function is becoming available through commercial reference laboratories. By abnormal tests is usually made repeat testing and also genetic testing.",
            "score": 76.93061566352844
        },
        {
            "docid": "47838669_3",
            "document": "LRBA deficiency . LRBA deficiency presents as a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency. Predominant clinical problems include idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia (AIHA), and an autoimmune enteropathy. Before the discovery of these gene mutations, patients were diagnosed with common variable immune deficiency (CVID), which is characterized by low antibody levels and recurrent infections. Infections mostly affect the respiratory tract, as many patients suffer from chronic lung disease, pneumonias, and bronchiectasis. Lymphocytic interstitial lung disease (ILD) is also observed, which complicates breathing and leads to impairment of lung function and mortality. Infections can also occur at other sites, such as the eyes, skin and gastrointestinal tract. Many patients suffer from chronic diarrhea and inflammatory bowel disease. Other clinical features can include hepatosplenomegaly, reoccurring warts, growth retardation, allergic dermatitis, and arthritis. Notably, LRBA deficiency has also been associated with type 1 diabetes mellitus. There is significant clinical phenotypic overlap with disease caused by CTLA4 haploinsufficiency. Since LRBA loss results in a loss of CTLA4 protein, the immune dysregulation syndrome of LRBA deficient patients can be attributed to the secondary loss of CTLA4. Because the predominant features of the disease include autoantibody-mediated disease (AIHA, ITP), Treg defects (resembling those found in CTLA4 haploinsufficient patients), autoimmune infiltration (of non-lymphoid organs, also resembling that found in CTLA4 haploinsufficient patients), and enteropathy, the disease has been termed LATAIE for LRBA deficiency with autoantibodies, Treg defects, autoimmune infiltration, and enteropathy.",
            "score": 94.99386537075043
        },
        {
            "docid": "2497276_16",
            "document": "Public health surveillance . Laboratory registries allow for the analysis of the incidence and prevalence of the target condition as well as trends in the level of control. For instance, an NIH-funded program called the Vermedx Diabetes Information System maintained a registry of laboratory values of diabetic adults in Vermont and northern New York State in the US with several years of laboratory results on thousands of patients. The data included measures of blood sugar control (glycosolated hemoglobin A1C), cholesterol, and kidney function (serum creatinine and urine protein), and were used to monitor the quality of care at the patient, practice, and population levels. Since the data contained each patient's name and address, the system was also used to communicate directly with patients when the laboratory data indicated the need for attention. Out of control test results generated a letter to the patient suggesting they take action with their medical provider. Tests that were overdue generated reminders to have testing performed. The system also generated reminders and alerts with guideline-based advice for the practice as well as a periodic roster of each provider's patients and a report card summarizing the health status of the population. Clinical and economic evaluations of the system, including a large randomized clinical trial, demonstrated improvements in adherence to practice guidelines and reductions in the need for emergency department and hospital services as well as total costs per patient. The system has been commercialized and distributed to physicians, insurers, employers and others responsible for the care of chronically ill patients. It is now being expanded to other conditions such as chronic kidney disease.",
            "score": 63.26820087432861
        },
        {
            "docid": "2834063_16",
            "document": "Peanut allergy . Oral food challenges pose risks. In a study of 584 oral food challenges administered to 382 patients, 48% (253) of challenges resulted in allergic reactions. 28% (72) of these challenges resulted in \"severe\" reactions, which were defined by the study as a patient having: lower respiratory symptoms; cardiovascular symptoms; or any four other, more minor, symptoms. Double-blind placebo-controlled oral food challenges are also time consuming and require close medical supervision. Because of these drawbacks to the double-blind placebo-controlled oral food challenge, open food challenges are the most commonly used form of food challenge. Open food challenges are those in which a patient is fed an age-appropriate serving of a suspected food allergen in its natural form. The observation of objective symptoms resulting from ingestion of the food, such as vomiting or wheezing, is considered diagnostic of food allergy if the symptoms correlate with findings from the patient\u2019s medical history and laboratory testing such as the skin prick test.",
            "score": 59.659717440605164
        },
        {
            "docid": "17475959_47",
            "document": "Plasma cell dyscrasia . \u03b1 Heavy chain disease (also termed immunoproliferative small intestinal disease or IPSID, Mediterranean lymphoma, and Seligmann disease) afflicts primarily individuals of Mediterranean, North African, and Middle Eastern descent of lower economic status. Many cases are centered in the Middle East and associated with relatively unsanitary living conditions. The disease usually appears between the ages 10 and 30 and in some cases may be an aberrant immune response to a parasite or other microorganism. The disease commonly effects the gastrointestinal tract leading to signs and symptoms of a malabsorption syndrome or, far less commonly, the respiratory tract with signs and symptoms of respiratory dysfunction. Involved tissues usually include mucosa-associated lymphoid tissues and evidence a histology of lymphoplasmacytoid infiltrates accompanied by large numbers of plasma cells and small lymphocytes. The plasma cells therein express the monoclonal \u03b1 chain and therefore are clonal in nature and the sole or contributing producer of the \u03b1 chain myeloma protein. Some 57% to 66% of patients present with disseminated lymphoma, 17% to 36% of patients present with a localized lymphoma, and 9% to 17% of patients lack any evidence of a lymphoplasmacytic neoplasm. A majority of the latter patients have an autoimmune disease or a chronic infection which may be responsible for, or contribute to, production of the \u03b1 heavy chain. Studies indicated that a sub-set particularly of the digestive form of heavy chain disease is caused by infection. This is based on findings that the majority of \u03b1 heavy chain disease patients are in the lower economic class living under unsanitary conditions, that gastrointestinal bacterial and parasitic infections have been documented in many of these patients, and that long-term (>6 months) appropriately selected antibiotic therapy has improved the condition in 33% to 71% of patients who are at an early stage of the disease and documented to be infected. However, these patients frequently relapse. Patients resistant to antibiotic trials have been treated with multiple drug chemotherapy to obtain complete remission rates of 64% and an overall 5 year survival of 67%.",
            "score": 80.87774097919464
        },
        {
            "docid": "17475959_40",
            "document": "Plasma cell dyscrasia . Multiple myeloma occurring concurrently with chronic Lymphocytic Leukemia or its pre-malignant precursor, monoclonal B-cell lymphocytosis, is an extremely rare condition in which patients evidence findings of the plasma cell dyscrasia plus either one of the cited clonal lymphocytic diseases. Patients are typically elderly (median age of 74, range 42\u201391 years old) males (51 of 66 case reports) and commonly present with a combination of symptoms related to chronic lymphocytic leukemia symptoms (fatigue, autoimmune hemolytic anemia, enlargements of liver and/or spleen and lymphadenopathy) plus symptoms of multiple myelomas. Patients exhibit two distinct populations of clonal cells in their bone marrow, blood, and/or other tissues: plasma cells, which may have a immature plasmablastic morphology and small lymphocytes, which have a morphology typical of chronic lymphocytic leukemia cells. Patients blood and/or urine evidences a plasma cell-derived myeloma proteins, either IgG, IgA, or free light chain in ~50%, 20%, and 20% of cases, respectively, but may also have a second myeloma protein made by the lymphocytic cells, either an IgM or IgG. Signs and symptoms of chronic lymphocytic leukemia commonly precede those of multiple myeloma, sometimes by years. The relationship(s) between the two clones of cells in this combined disease has not been established although one study suggests that the clonal plasma cells and clonal lymphocytes arise from a common hematological stem cell. In general, patients with plasma cell myeloma with concomitant chronic Lymphocytic Leukemia/monoclonal B-cell Lymphocytosis have been treated with the same regimens used for multiple myeloma patients unless significant complications related to the lymphocytic component of their disease (e.g. autoimmune hemolytic anemia) require treatments used in chronic lymphocytic leukemia. Some patients who lack appreciable symptoms have been followed with no specific treatment of their disease.",
            "score": 62.27337920665741
        },
        {
            "docid": "52195015_4",
            "document": "Suvendra Nath Bhattacharyya . Bhattacharyya's researches at RBRL is mainly on microRNA (miRNA), focusing on its compartmentalization, regulation and mediation as well as its alteration in Leishmania invaded macrophage and neighboring non-macrophage cells. His researches assisted in identifying cholesterol as a modulator in leishmaniasis infection and his team has developed a therapeutic protocol for treating leishmaniasis by administering microRNA molecules in patients which has been found to raise the cholesterol level which in turn reduced the parasite levels. The treatment, combined with other drugs have been reported to be effective in treating the disease commonly known as Kala azar, which has a reported high drug resistance. One of his earlier projects, \"Mechanism of mRNA compartmentalization in the cytoplasm of mammalian cells\", was funded by the Wellcome Trust. On his current project, \"miRNA expoprt and Stability\", he has worked on the mammalian immune and cancer cells and reportedly discovered miRNA activity modulation mechanisms in those cells.",
            "score": 78.30569815635681
        },
        {
            "docid": "5650081_5",
            "document": "Hunter syndrome . Hunter syndrome may present with a wide variety of phenotypes. Hunter syndrome has traditionally been categorized as either \"mild\" or \"severe\" depending on the presence of central nervous system symptoms. However, this is an oversimplification. Patients with \"attenuated\" or \"mild\" forms of the disease may still suffer from significant health issues. For severely affected patients, the clinical course is relatively predictable; patients will normally die at an early age. For those with milder forms of the disease, there is a wider variety of outcomes. Many live into their 20s and 30s, but some may have near-normal life expectancies and may even have children. Cardiac and respiratory abnormalities are the usual cause of death for patients with milder forms of the disease.",
            "score": 83.09035658836365
        },
        {
            "docid": "49594540_2",
            "document": "Functional neurological symptom disorder . A functional neurological disorder (FND) is a condition in which patients experience neurological symptoms such as weakness, movement disorders, sensory symptoms and blackouts. The brain of a patient with functional neurological symptom disorder is structurally normal, but functions incorrectly. According to consensus from the literature and from physicians and psychologists practicing in the field, functional symptoms are also called 'medically unexplained'. Historically, other terms have been used to describe these symptoms. Symptoms of functional neurological disorders are clinically recognisable, but are not categorically associated with a definable organic disease. The intended contrast is with an organic brain syndrome, although the terms imply a level of certainty about causation that is often clinically unconfirmed. Subsets of functional neurological disorders include functional neurological symptom disorder (FNsD), conversion disorder, and psychogenic movement disorder/non-epileptic seizures. Functional neurological disorders are common in neurological services, accounting for up to one third of outpatient neurology clinic attendances, and associated with as much physical disability and distress as other neurological disorders. The diagnosis is made based on positive signs and symptoms in the history and examination during consultation of a neurologist (see below). Physiotherapy is particularly helpful for patients with motor symptoms (weakness, gait disorders, movement disorders) and tailored cognitive behavioural therapy has the best evidence in patients with dissociative (non-epileptic) attacks.",
            "score": 76.12379467487335
        },
        {
            "docid": "7041908_11",
            "document": "Basidiobolus ranarum . Definitive diagnosis requires laboratory effort. Culture, histopathology and immunology can be used to for the diagnosis. First, a portion of the infected tissue will be surgically removed and used for a biopsy. Since the fungus can not tolerate refrigeration, the biopsied material needs to be incubated immediately once it is collected. Then, the examination will investigate the presence of thin-walled, wide, hyaline, coenocytic hyphae and internal cleavage for the production of the sporangiospores in H&E (Haemotoxylin and Eosin) stained sections. Other characteristics of its appearance mentioned in the morphology section might also be used to identify the species. Moreover, the histopathology test will expect a granuloma consisting of a variety of immune cells in which hypha or hyphal fragments (4\u201310 \u03bcm diameter) often stain bright pink in H&E sections. When biopsy is not available, immunofluorescent test can also be used to identify \"B. ranarum\" strains. Five specific antigens have been identified that can be used measured in the sera of the infected patients using antibodies conjugated to fluorescein dye. The diagnosis of the rare cases, such as gastrointestinal basidiobolomycosis, is challenging given the nonspecific clinical presentation as well as the need for surgical biopsy.",
            "score": 54.06379806995392
        },
        {
            "docid": "47365198_8",
            "document": "Baggio\u2013Yoshinari syndrome . The first cases were described in Brazil in 1992 in siblings from Cotia, S\u00e3o Paulo that developed symptoms as a migrating redness, general flu-like symptoms and arthritis after being bitten by ticks. Although the symptoms were similar to those presented by patients of Lyme disease, clinical and laboratorial results were considerably different. Ticks of the \"Ixodes ricinus\" complex were not found at the risk areas; bacteria from the \"Borrelia burgdorferi\" sensu lato complex \u2014that cause Lyme disease\u2014 were not found in biological fluids and tissues of the siblings. Blood analysis of the patients on electron microscopy exhibited structures resembling microorganisms of the spirochaete phylum. For these reasons, the Brazilian zoonosis was considered a new disease and named Baggio\u2013Yoshinari Syndrome (BYS), defined as: \"Exotic and emerging Brazilian infectious disease, transmitted by ticks not belonging to the \"Ixodes ricinus\" complex, caused by latent spirochetes with atypical morphology, which originates LD-like symptoms, except for occurrence of relapsing episodes and auto-immune disorders\".",
            "score": 70.65837717056274
        },
        {
            "docid": "1395311_24",
            "document": "Food intolerance . IgG4 tests are invalid; IgG4 presence indicates that the person has been repeatedly exposed to food proteins recognized as foreign by the immune system which is a normal physiological response of the immune system after exposure to food components. Although elimination of foods based on IgG-4 testing in IBS patients resulted in an improvement in symptoms, the positive effects of food elimination were more likely due to wheat and milk elimination than IgG-4 test-determined factors. The IgG-4 test specificity is questionable as healthy individuals with no symptoms of food intolerance also test positive for IgG-4 to several foods.",
            "score": 58.468092918395996
        },
        {
            "docid": "2217913_13",
            "document": "Hemiballismus . Complications from HIV infection Patients with HIV often have complications that arise along with AIDS. Hypoglycemia due to pentamidine use in patients with AIDS has been known to cause hemiballismus. In some patients, hemiballismus has been the only visible symptom to alert the physician that the patients may have AIDS. It is typically a result of a secondary infection that occurs due to the compromised immune system and the most common infection causing hemiballismus is cerebral toxoplasmosis. Most of the lesions that result from this infection are found in the basal ganglia. As long as the diagnosis is not missed, this type of hemiballismus can be treated just as well as in patients without HIV.",
            "score": 79.40472459793091
        },
        {
            "docid": "3952243_24",
            "document": "Involuntary memory . Psychosis is defined as a range of perceptual presentations, with the associated symptoms frequently referred to as either \"positive\" or \"negative\". Positive symptoms are delusional, and may include hallucinations, while negative symptoms are characterized by a \"lack\" of functioning, which may include a lack of affect (emotional feeling) and loss of motivation. One study found that there was a high prevalence of trauma in patients with severe mental illness. However, only a small percentage had been diagnosed with PTSD when displaying PTSD-like symptoms. Therefore, the more complex symptoms of psychosis may prevent the clinical detection required when diagnosing PTSD. In addition, those who have been diagnosed with PTSD and have an identified form of trauma show positive symptoms of psychosis such as delusions and/or hallucinations. Finally, it has been suggested that individuals suffering from psychosis may be more vulnerable to intrusions.",
            "score": 68.42519235610962
        },
        {
            "docid": "2930584_7",
            "document": "Visceral leishmaniasis . Response to infection by \"Leishmania donovani\" varies a great deal, not only by the strength but also by the type of the patient's immune reaction. People with a history of infection by strains of leishmania that cause visceral leishmaniasis show a continuum of immune responses from protective to non-protective. Those who acquired protective immunity (skin test positive) without ever having visceral leishmaniasis have a strong type 1 CD4+ response to leishmania antigens. Antigen specific interferon-gamma and proliferation, as well as the ability to kill intracellular leishmania, are hallmarks of protective immunity. Because visceral leishmaniasis patients lack these responses to leishmania and other antigens, they usually die of secondary infections if left untreated. In addition, increased interleukin-10 secretion is characteristic of the disease. Addition of interleukin-12, anti-interleukin-10, or anti-interleukin-4 to peripheral blood mononuclear cells from acute patients sometimes increases interferon-gamma secretion and proliferation. Acute patient peripheral blood mononuclear cells include CD8+ T regulatory cells that decrease interferon-gamma secretion and proliferation responses to leishmania and other antigens and increase interleukin-10 secretion when added to autologous peripheral blood mononuclear cells harvested after successful treatment. Thus, the CD8+ T regulatory cells reproduce the immune response characteristic of visceral leishmaniasis. CD8+ T regulatory cells are also associated with post kala azar dermal leishmaniasis. Addition of interleukin-12 or interferon-gamma does not prevent CD8+ T regulatory activity. The dominance of type 1 CD4+ T cells in skin test positive adults maybe explained by their secretion of factors that inhibit and kill CD8+ T regulatory cells. Successfully treated patients rarely develop visceral leishmaniasis a second time. Their peripheral blood mononuclear cells show a mixed T1/T2 CD4+ and CD8+ T suppressor response but do have the ability to kill intracellular leishmania.",
            "score": 111.76143956184387
        },
        {
            "docid": "37796_19",
            "document": "West Nile fever . In fatal cases, nucleic acid amplification, histopathology with immunohistochemistry, and virus culture of autopsy tissues can also be useful. Only a few state laboratories or other specialized laboratories, including those at CDC, are capable of doing this specialized testing. A number of various diseases may present with symptoms similar to those caused by a clinical West Nile virus infection. Those causing neuroinvasive disease symptoms include the enterovirus infection and bacterial meningitis. Accounting for differential diagnoses is a crucial step in the definitive diagnosis of WNV infection. Consideration of a differential diagnosis is required when a patient presents with unexplained febrile illness, extreme headache, encephalitis or meningitis. Diagnostic and serologic laboratory testing using polymerase chain reaction (PCR) testing and viral culture of CSF to identify the specific pathogen causing the symptoms, is the only currently available means of differentiating between causes of encephalitis and meningitis.",
            "score": 77.19850540161133
        },
        {
            "docid": "1171686_14",
            "document": "Regulatory T cell . Studies of human subjects with a history of leishmania infection suggest that modulation of CD8 suppressor T cells is, at least partly, mediated by cytokines. Leishmania specific CD4 helper T cells predominate in adults with strong protective immunity (skin-test positive with no history of clinical infection). When added to autologous leishmania infected macrophages these T cells cause parasite death and secretion of large amounts of interferon-gamma and lymphotoxin. CD8 T suppressor cells predominate in patients with no protective immunity (visceral leishmaniasis patients). When added to autologous peripheral blood mononuclear cells isolated after successful treatment, these T cells inhibit interferon-gamma secretion and proliferation and increase interleukin-6 and interleukin-10 secretion. A soluble factor(s) generated by antigen or phytohemagglutinin stimulation of leishmania-specific CD4 helper T cells from skin-test positive adults killed CD8 T cells but not CD4 helper T cells when added to culture media. Soluble factors generated by antigen stimulation of peripheral blood mononuclear cells from skin-test positive adults prevented CD8 suppressor T cell mediated increases in interleukin-10 secretion. These findings suggest that antigen stimulation of CD4 helper T cells results in production of cytokines that kill or down regulate CD8 T suppressor cells. Once the leishmania infection has been eliminated and leishmania antigens are gone, CD8 T suppressor cells down-regulate CD4 T helper cells. Isolation of cytokines that inhibit and kill CD8 T suppressor cells might be useful in treating diseases that involve immune suppression such as leishmaniasis, AIDS, and certain cancers.",
            "score": 90.42310190200806
        },
        {
            "docid": "23804284_11",
            "document": "African tick bite fever . Many patients with ATBF who live in areas with a high number of infections (Africa and the West Indies) do not visit a doctor, as most patients only have mild symptoms. This disease can, however, cause more serious symptoms in travelers who have never been exposed to the \"Rickettsia africae\" bacterium before and are not immune. Travelers who present to a doctor after a trip to affected areas can be hard to diagnose, as many tropical diseases cause a fever similar to that of ATBF. Other diseases that may look similar are malaria, dengue fever, tuberculosis, acute HIV and respiratory infections. In addition to questions about symptoms, doctors will ask patients for an accurate travel history and whether he/she was near animals or ticks. Microbiological tests are available for doctors, but are expensive and often must be done by special laboratories.",
            "score": 79.61996150016785
        },
        {
            "docid": "2525632_6",
            "document": "Carnitine palmitoyltransferase II deficiency . This exclusively myopathic form is the most prevalent and least severe phenotypic presentation of this disorder. Characteristic signs and symptoms include rhabdomyolysis (breakdown of muscle fibers and subsequent release of myoglobin), myoglobinuria, recurrent muscle pain, and weakness. It is important to note that muscle weakness and pain typically resolves within hours to days, and patients appear clinically normal in the intervening periods between attacks. Symptoms are most often exercise-induced, but fasting, a high-fat diet, exposure to cold temperature, sleep deprivation, or infection (especially febrile illness) can also provoke this metabolic myopathy. In a minority of cases, disease severity can be exacerbated by three life-threatening complications resulting from persistent rhabdomyolysis: acute kidney failure, respiratory insufficiency, and episodic abnormal heart rhythms. Severe forms may have continual pain from general life activity. The adult form has a variable age of onset. The first appearance of symptoms usually occurs between 6 and 20 years of age but has been documented in patients as young as 8 months as well as in adults over the age of 50. Roughly 80% cases reported to date have been male.",
            "score": 74.2408013343811
        },
        {
            "docid": "2366736_21",
            "document": "Oropouche fever . One study has focused on identifying OROV through the use of RNA extraction from reverse transcription-polymerase chain reaction. This study revealed that OROV caused central nervous system infections in three patients. The three patients all had meningoencephalitis and also showed signs of clear lympho-monocytic cellular pattern in CSF, high protein, and normal to slightly decreased glucose levels indicating they had viral infections. Two of the patients already had underlying infections that can effect the CNS and immune system and in particular one of these patients has HIV/AIDS and the third patient has neurocysticercosis. Two patients were infected with OROV developed meningitis and it was theorized that this is due to them being immunocompromised. Through this it was revealed that it's possible that the invasion of the central nervous system by the oropouche virus can be performed by a pervious blood-brain barrier damage.",
            "score": 79.72084856033325
        },
        {
            "docid": "38187439_3",
            "document": "Atypical hemolytic uremic syndrome . Clinical signs and symptoms of complement-mediated TMA can include abdominal pain, confusion, fatigue, edema (swelling), nausea/vomiting and diarrhea. aHUS often presents with malaise and fatigue, as well as microangiopathic anemia. However, severe abdominal pain and bloody diarrhea are unusual. Laboratory tests may also reveal low levels of platelets (cells in the blood that aid in clotting), elevated lactate dehydrogenase (LDH, a chemical released from damaged cells, and which is therefore a marker of cellular damage), decreased haptoglobin (indicative of the breakdown of red blood cells), anemia (low red blood cell count)/schistocytes (damaged red blood cells), elevated creatinine (indicative of kidney dysfunction), and proteinuria (indicative of kidney injury). Patients with aHUS often present with an abrupt onset of systemic signs and symptoms such as acute kidney failure, hypertension (high blood pressure), myocardial infarction (heart attack), stroke, lung complications, pancreatitis (inflammation of the pancreas), liver necrosis (death of liver cells or tissue), encephalopathy (brain dysfunction), seizure, or coma. Failure of neurologic, cardiac, kidney, and gastrointestinal (GI) organs, as well as death, can occur unpredictably at any time, either very quickly or following prolonged symptomatic or asymptomatic disease progression. For example, approximately 1 in 6 patients with aHUS initially will present with proteinuria or hematuria without acute kidney failure. Patients who survive the presenting signs and symptoms endure a chronic thrombotic and inflammatory state, which puts many of them at lifelong elevated risk of sudden blood clotting, kidney failure, other severe complications and premature death.",
            "score": 64.27567970752716
        },
        {
            "docid": "422247_35",
            "document": "Self-awareness . Schizophrenia as a disease state is characterized by severe cognitive dysfunction and it is uncertain to what extent patients are aware of this deficiency. Medalia and Lim (2004), investigated patients\u2019 awareness of their cognitive deficit in the areas of attention, nonverbal memory, and verbal memory. Results from this study (N=185) revealed large discrepancy in patients\u2019 assessment of their cognitive functioning relative to the assessment of their clinicians. Though it is impossible to access ones\u2019 consciousness and truly understand what a schizophrenic believes, regardless in this study, patients were not aware of their cognitive dysfunctional reasoning. In the DSM-5, to receive a diagnosis of schizophrenia, they must have two or more of the following symptoms in the duration of one month: delusions*, hallucinations*, disorganized speech*, grossly disorganized/catatonic behavior and negative symptoms (*these three symptoms above all other symptoms must be present to correctly diagnose a patient.) Sometimes these symptoms are very prominent and are treated with a combination of antipsychotics (i.e. haloperidol, loxapine), atypical antipsychotics (such as clozapine and risperdone) and psychosocial therapies that include family interventions and socials skills. When a patient is undergoing treatment and recovering from the disorder, the memory of their behavior is present in a diminutive amount; thus, self-awareness of diagnoses of schizophrenia after treatment is rare, as well as subsequent to onset and prevalence in the patient.",
            "score": 71.62855339050293
        },
        {
            "docid": "50922781_8",
            "document": "NEMO deficiency syndrome . The clinical presentation of NEMO deficiency is determined by three main symptoms:  To determine whether or not patient has NEMO deficiency, an immunologic screen to test immune system response to antigen may be used although a genetic test is the only way to be certain as many individuals respond differently to the immunological tests.",
            "score": 65.07318472862244
        },
        {
            "docid": "26652093_11",
            "document": "Autologous immune enhancement therapy . Though the concept of this treatment started in the US in 1980s, full-fledged clinical treatments on a routine basis have been in practice in Japan since 1990. Randomized controlled studies in different cancers with significant increase in survival and disease free period have been reported. In India immunotherapy has shown positive results in patients with advanced cancer including acute myeloid leukaemia, pancreatic cancer, Cervical Cancer, Ovarian cancer, Breast Cancer and Philadelphia chromosome Positive Acute Lymphoblastic Leukemia. Auto-Immune diseases like the Auto-Immune Hemolytic Anemia (AIHA) have been known to be associated with malignancies. In general lower Natural Killer (NK) profile has been associated with development of cancers by earlier studies. Recently an article has been published in which it has been described that the in vitro expansion of NK cells is decreased in cancer patients who have concomitant Auto-immune Diseases like the AIHA. This study also throws questions on whether AIHA is a complication of malignancies, due to the lower NK cell profile in cancer which would have given rise to the AIHA due to some common antibody between NK cells and Red Blood Cells (RBCs) or whether the AIHA lowers the NK cell profile which in turn causes the cancer. This warrants further investigations into the identification of common antibodies between NK cells & RBCs and also finding new Immuno- therapeutic strategies which can tackle both cancer and auto-immunity",
            "score": 63.82199776172638
        },
        {
            "docid": "466746_16",
            "document": "Mycoplasma pneumoniae . Diagnosis of \"Mycoplasma pneumoniae\" infections is complicated by the delayed onset of symptoms and the similarity of symptoms to other pulmonary conditions. Often, \"M. pneumoniae\" infections are diagnosed as other conditions and, occasionally, non-pathogenic mycoplasmas present in the respiratory tract are mistaken for \"M. pneumoniae\". Historically, diagnosis of \"M. pneumoniae\" infections was made based on the presence of cold agglutinins and the ability of the infected material to reduce tetrazolium. Causative diagnosis is dependent upon laboratory testing, however these methods are more practical in epidemiological studies than in patient diagnosis. Culture tests are rarely used as diagnosic tools; rather immunoblotting, immunofluorescent staining, hemadsorption tests, tetrazolium reduction, metabolic inhibition tests, serological assays, and polymerase chain reaction (PCR) are used for diagnosis and characterization of bacterial pneumonic infections. PCR is the most rapid and effective way to determine the presence of \"M. pneumoniae\", however the procedure does not indicate the activity or viability of the cells present. EIA serological assays are the most common method of \"M. pneumoniae\" detection used in patient diagnosis due to the low cost and relatively short testing time. One drawback of serology is that viable organisms are required, which may overstate the severity of infection. Neither of these methods, along with others, has been available to medical professionals in a rapid, efficient and inexpensive enough form to be used in routine diagnosis, leading to decreased ability of physicians to diagnose \"M. pneumoniae\" infections.",
            "score": 71.99721252918243
        },
        {
            "docid": "42488624_11",
            "document": "Paragonimus skrjabini . In humans, \"P. skrjabini\" infections can result in a wide variety of symptoms, rendering it difficult to diagnose and challenging to quickly enact proper treatment. Diagnosis typically requires first a general recognition of the symptoms followed by laboratory and radiologic tests. Radiology, for example, can pick up on \"P. skrjabini's\" migration to ectopic places like the brain. Serological or immunological tests including intradermal test, immunodiffusion, indirect haemagglutination test, enzyme-linked immunosorbent assay, and Western blot also play a key role in not only diagnosing the overall presence of \"Paragonimus\" parasites in the body but also distinguishing the various different species invading. The ELISA test detects the antibody used to combat the \"P. skrjabini\" infection. Although cases of \"P. skrjabini\" infection can exhibit early symptoms such as abdominal pain, a lack of appetite, and high fever, it can also come on slowly and fail to exhibit identifiable symptoms for a period of latency between 20 days to as long as 3 months. Later on in the infection, the type of symptoms that appear primarily depends on which organs the \"P. skrjabini\" parasites enter. Infections and the resulting set of symptoms can be classified under five different types including the subcutaneous mass type, cerebral type, pericarditis type, abdominal type, and pleurisy type. Infections of the pleurisy type, for instance, exhibit symptoms like chest pain and cough while the cerebral type tends to result in vomiting and headaches. The pericarditis type is associated with shortness of breath and palpitation while the abdominal type infections lead to diarrhea and abdominal pain. \"P. skrjabini\" has shown no effect on mammalian reproductive abilities. Despite occasional cases resulting in death, \"P. skrjabini\" has not been widely known to cause morbidity and death. Surgery may be occasionally necessary for patients with cerebal or pleural paragonimiasis.",
            "score": 74.00212359428406
        },
        {
            "docid": "629684_2",
            "document": "Immunodeficiency . Immunodeficiency (or immune deficiency) is a state in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. Most cases of immunodeficiency are acquired (\"secondary\") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection, extremes of age, and environmental factors, such as nutrition. In the clinical setting, the immunosuppression by some drugs, such as steroids, can be either an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency. A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised person may be particularly vulnerable to opportunistic infections, in addition to normal infections that could affect everyone. Immunodeficiency also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.",
            "score": 86.41895353794098
        },
        {
            "docid": "47622142_4",
            "document": "PGM3 deficiency . In addition to severe immunodeficiency, motor and neurologic impairment are evident from early life. Oral motor deficits, dysarthria, developmental delay, ataxia, myoclonus, seizure and mild sensory loss have all been identified. These distinctive neurologic features are suggestive of hypomyelination, as they resemble features of other congenital disorder of glycosylation (CDGs). Because glycosylation is known to be critical for numerous immune-related proteins, these patients likely present with additional abnormalities including neutropenia, hemolytic anemia, hepatosplenomegaly, and neutropenia. An immunologic mechanism to explain the link between glycosylation abnormalities and the immune dysregulation has not yet been established. This disorder demonstrates a previously unappreciated importance that glycosylation can have on the immune response and more research is needed to examine the precise mechanism by which these mutations and abnormal glycosylation lead to the clinical defects observed",
            "score": 62.48118031024933
        },
        {
            "docid": "7663818_16",
            "document": "Management of multiple sclerosis . Interferons, a subclass of cytokines, are produced in the body during illnesses such as influenza in order to help fight the infection. They are responsible of many of the symptoms of influenza infections, including fever, muscle aches, fatigue, and headaches. Many patients report influenza-like symptoms hours after taking interferon-beta that usually improve within 24 hours, being such symptoms related to the temporary increase of cytokines. This reaction tends to disappear after 3 months of treatment and its symptoms can be treated with over-the-counter nonsteroidal anti-inflammatory drugs, such as ibuprofen, that reduce fever and pain. Another common transient secondary effect with interferon-beta is a functional deterioration of already existing symptoms of the disease. Such deterioration is similar to the one produced in MS patients due to heat, fever or stress (Uhthoff's phenomenon), usually appears within 24 hours of treatment, is more common in the initial months of treatment, and may last several days. A symptom specially sensitive to worsening is spasticity. Interferon-beta can also reduce numbers of white blood cells (leukopenia), lymphocytes (lymphopenia) and neutrophils (neutropenia), as well as affect liver function. In most cases these effects are non-dangerous and reversible after cessation or reduction of treatment. Nevertheless, recommendation is that all patients should be monitored through laboratory blood analyses, including liver function tests, to ensure safe use of interferons.",
            "score": 73.17054533958435
        },
        {
            "docid": "3387097_7",
            "document": "Cyclospora cayetanensis . \"C. cayentanensis\" causes gastroenteritis, with the extent of the illness varying based on age, condition of the host, and size of the infectious dose. Symptoms include \"watery diarrhea, loss of appetite, weight loss, abdominal bloating and cramping, increased flatulence, nausea, fatigue, and low-grade fever\", though this can be augmented in more severe cases by vomiting, substantial weight loss, excessive diarrhea, and muscle aches. Typically, patients with a persistent watery diarrhea lasting over several days may be suspected of harboring the disease, especially if they have traveled to a region where the protozoan is endemic. The incubation period in the host is typically around a week, and illness can last six weeks before self-limiting. Unless treated, illness may relapse. The more severe forms of the disease can occur in immunocompromised patients, such as those with AIDS. Human cyclosporiasis is clinically similar to cryptosporidiosis, isosporiasis, giardiasis and microsporidiosis because of the similar clinical features. Flu like syndrome with myalgias and arthralgias may precede the onset of diarrhea. Fever is low grade and is unusual. There is presence of moderate to severe dehydration, compensatory tachycardia, systolic blood pressure (SBP<90 mmHg) and decreased skin turgor may occur. But mild infection produces few or no clinical symptoms. The immune system may determine the appearance of symptoms; that is, from symptomatic to asymptomatic stage depends on resistivity of the immune system.",
            "score": 91.3841108083725
        }
    ],
    "r": [
        {
            "docid": "2930584_7",
            "document": "Visceral leishmaniasis . Response to infection by \"Leishmania donovani\" varies a great deal, not only by the strength but also by the type of the patient's immune reaction. People with a history of infection by strains of leishmania that cause visceral leishmaniasis show a continuum of immune responses from protective to non-protective. Those who acquired protective immunity (skin test positive) without ever having visceral leishmaniasis have a strong type 1 CD4+ response to leishmania antigens. Antigen specific interferon-gamma and proliferation, as well as the ability to kill intracellular leishmania, are hallmarks of protective immunity. Because visceral leishmaniasis patients lack these responses to leishmania and other antigens, they usually die of secondary infections if left untreated. In addition, increased interleukin-10 secretion is characteristic of the disease. Addition of interleukin-12, anti-interleukin-10, or anti-interleukin-4 to peripheral blood mononuclear cells from acute patients sometimes increases interferon-gamma secretion and proliferation. Acute patient peripheral blood mononuclear cells include CD8+ T regulatory cells that decrease interferon-gamma secretion and proliferation responses to leishmania and other antigens and increase interleukin-10 secretion when added to autologous peripheral blood mononuclear cells harvested after successful treatment. Thus, the CD8+ T regulatory cells reproduce the immune response characteristic of visceral leishmaniasis. CD8+ T regulatory cells are also associated with post kala azar dermal leishmaniasis. Addition of interleukin-12 or interferon-gamma does not prevent CD8+ T regulatory activity. The dominance of type 1 CD4+ T cells in skin test positive adults maybe explained by their secretion of factors that inhibit and kill CD8+ T regulatory cells. Successfully treated patients rarely develop visceral leishmaniasis a second time. Their peripheral blood mononuclear cells show a mixed T1/T2 CD4+ and CD8+ T suppressor response but do have the ability to kill intracellular leishmania.",
            "score": 111.76144409179688
        },
        {
            "docid": "2930584_16",
            "document": "Visceral leishmaniasis . There are a number of problems with serological testing: in highly endemic areas, not everyone who becomes infected will actually develop clinical disease or require treatment. Indeed, up to 32% of the healthy population may test positive, but not require treatment. Conversely, because serological tests look for an immune response and not for the organism itself, the test does not become negative after the patient is cured, it cannot be used as a check for cure, or to check for re-infection or relapse. Likewise, patients with abnormal immune systems (e.g., HIV infection) will have false-negative tests.",
            "score": 102.78413391113281
        },
        {
            "docid": "20763865_11",
            "document": "Leishmania donovani . \"L. donovani\" is the causative agent of visceral leishmaniasis, traditionally known as \"kala-azar\" (\"black fever\", particularly in India), because of its characteristic symptoms. The disease is highly lethal if not treated properly. The incubation period generally ranges from 3 to 6 months, and in some cases may be over a year. In Indian leishmaniasis, incubation can be as short as 10 days. The target cells are those of mononuclear phagocyte system. The two main tissues of infection are spleen and liver. Clinical symptoms include pyrexia (recurring high fever which may be continuous or remittent), enlargement of spleen and liver, and heavy skin pigmentation which darkens the physical appearance (the reason for naming \"black fever\"). To a lesser extent mucosa of the small intestine and lymph nodes are also invaded by the parasite. Morphological symptoms are noticeable particularly on facial and abdominal regions. Skin becomes coarse and hard. In African infections, warty eruptions are common. In a fully developed stage, the patient shows emaciation and anaemia. Where medical facilities are poor, mortality can be as high as 75\u201395% within 2 years of epidemics. The disease is often accompanied by complications with dysentery, tuberculosis, septicaemia and even HIV infection.",
            "score": 101.90762329101562
        },
        {
            "docid": "2930584_5",
            "document": "Visceral leishmaniasis . When people develop visceral leishmaniasis, the most typical symptoms are fever and the enlargement of the spleen, with enlargement of the liver sometimes being seen as well. The blackening of the skin that gave the disease its common name in India does not appear in most strains of the disease, and the other symptoms are very easy to mistake for those of malaria. Misdiagnosis is dangerous, as without proper treatment the mortality rate for kala-azar is close to 100%. \"L. donovani\" itself is not usually the direct cause of death in kala-azar sufferers, however. Pneumonia, tuberculosis, and dysentery are omnipresent in the depressed regions where leishmaniasis thrives, and, as with AIDS, it is these opportunistic infections that are more likely to kill, flaring up in a host whose immune system has been weakened by the \"L. donovani\" infection. Progress of the disease is extremely variable, taking anywhere from one to twenty weeks, but a typical duration for the Sudanese strain of the disease is narrower, between twelve and sixteen weeks.",
            "score": 97.67106628417969
        },
        {
            "docid": "198491_2",
            "document": "Leishmaniasis . Leishmaniasis is a disease caused by parasites of the \"Leishmania\" type. It is spread by the bite of certain types of sandflies. The disease can present in three main ways: cutaneous, mucocutaneous, or visceral leishmaniasis. The cutaneous form presents with skin ulcers, while the mucocutaneous form presents with ulcers of the skin, mouth, and nose, and the visceral form starts with skin ulcers and then later presents with fever, low red blood cells, and enlarged spleen and liver. Infections in humans are caused by more than 20 species of \"Leishmania\". Risk factors include poverty, malnutrition, deforestation, and urbanization. All three types can be diagnosed by seeing the parasites under the microscope. Additionally, visceral disease can be diagnosed by blood tests. Leishmaniasis can be partly prevented by sleeping under nets treated with insecticide. Other measures include spraying insecticides to kill sandflies and treating people with the disease early to prevent further spread. The treatment needed is determined by where the disease is acquired, the species of \"Leishmania\", and the type of infection. Some possible medications used for visceral disease include liposomal amphotericin B, a combination of pentavalent antimonials and paromomycin, and miltefosine. For cutaneous disease, paromomycin, fluconazole, or pentamidine may be effective. About 4 to 12 million people are currently infected in some 98 countries. About 2 million new cases and between 20 and 50 thousand deaths occur each year. About 200\u00a0million people in Asia, Africa, South and Central America, and southern Europe live in areas where the disease is common. The World Health Organization has obtained discounts on some medications to treat the disease. It is classified as a neglected tropical disease. The disease may occur in a number of other animals, including dogs and rodents.",
            "score": 95.96919250488281
        },
        {
            "docid": "47838669_3",
            "document": "LRBA deficiency . LRBA deficiency presents as a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency. Predominant clinical problems include idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia (AIHA), and an autoimmune enteropathy. Before the discovery of these gene mutations, patients were diagnosed with common variable immune deficiency (CVID), which is characterized by low antibody levels and recurrent infections. Infections mostly affect the respiratory tract, as many patients suffer from chronic lung disease, pneumonias, and bronchiectasis. Lymphocytic interstitial lung disease (ILD) is also observed, which complicates breathing and leads to impairment of lung function and mortality. Infections can also occur at other sites, such as the eyes, skin and gastrointestinal tract. Many patients suffer from chronic diarrhea and inflammatory bowel disease. Other clinical features can include hepatosplenomegaly, reoccurring warts, growth retardation, allergic dermatitis, and arthritis. Notably, LRBA deficiency has also been associated with type 1 diabetes mellitus. There is significant clinical phenotypic overlap with disease caused by CTLA4 haploinsufficiency. Since LRBA loss results in a loss of CTLA4 protein, the immune dysregulation syndrome of LRBA deficient patients can be attributed to the secondary loss of CTLA4. Because the predominant features of the disease include autoantibody-mediated disease (AIHA, ITP), Treg defects (resembling those found in CTLA4 haploinsufficient patients), autoimmune infiltration (of non-lymphoid organs, also resembling that found in CTLA4 haploinsufficient patients), and enteropathy, the disease has been termed LATAIE for LRBA deficiency with autoantibodies, Treg defects, autoimmune infiltration, and enteropathy.",
            "score": 94.99386596679688
        },
        {
            "docid": "12874039_4",
            "document": "Alan Fairlamb . In 1985, Alan Fairlamb discovered a unique thiol compound present in these parasites, and named it trypanothione. This thiol metabolite is quite different from its human equivalent, glutathione. Trypanothione allows the parasites to fend off free radicals and other toxic oxidants produced by the immune system of the infected patient, and was shown to be vital for parasite survival and virulence. For instance, antimonials neutralize the Leishmania parasite\u2019s antioxidant defence system, allowing the patient to clear the infection. Studies on the effect of drugs on trypanothione metabolism resulted in the discovery that fexinidzole is a potential oral treatment for visceral leishmaniasis.",
            "score": 93.72138214111328
        },
        {
            "docid": "56598639_5",
            "document": "Innate immune defect . Interleukin-1 receptor-associated kinase deficiency is an inherited disorder of the immune system. This immunodeficiency leads to recurrent infections caused by the pyogenic bacteria, for example \"Streptococcus pneumoniae\", \"Staphylococcus aureus\" and \"Pseudomonas aeruginosa\", but not by other infectious agents. Most patients with IRAK-4 deficiency suffer from invasive bacterial infections, which can cause septicemia, meningitis or they affect the joints that can lead to inflammation and arthritis. These invasive infections can also cause areas of tissue breakdown and pus production (abscesses) on internal organs. In addition, patients are characterized by infections of the upper respiratory tract, eyes or skin. Although fever is a common reaction to bacterial infections, many people with IRAK-4 deficiency do not at first develop a high fever in response to these infections, even if the infection is severe. Most patients have their first bacterial infection before age 2, and the infections can be life-threatening in infancy and childhood. Infections become less frequent with age.",
            "score": 92.51998901367188
        },
        {
            "docid": "3387097_7",
            "document": "Cyclospora cayetanensis . \"C. cayentanensis\" causes gastroenteritis, with the extent of the illness varying based on age, condition of the host, and size of the infectious dose. Symptoms include \"watery diarrhea, loss of appetite, weight loss, abdominal bloating and cramping, increased flatulence, nausea, fatigue, and low-grade fever\", though this can be augmented in more severe cases by vomiting, substantial weight loss, excessive diarrhea, and muscle aches. Typically, patients with a persistent watery diarrhea lasting over several days may be suspected of harboring the disease, especially if they have traveled to a region where the protozoan is endemic. The incubation period in the host is typically around a week, and illness can last six weeks before self-limiting. Unless treated, illness may relapse. The more severe forms of the disease can occur in immunocompromised patients, such as those with AIDS. Human cyclosporiasis is clinically similar to cryptosporidiosis, isosporiasis, giardiasis and microsporidiosis because of the similar clinical features. Flu like syndrome with myalgias and arthralgias may precede the onset of diarrhea. Fever is low grade and is unusual. There is presence of moderate to severe dehydration, compensatory tachycardia, systolic blood pressure (SBP<90 mmHg) and decreased skin turgor may occur. But mild infection produces few or no clinical symptoms. The immune system may determine the appearance of symptoms; that is, from symptomatic to asymptomatic stage depends on resistivity of the immune system.",
            "score": 91.38410949707031
        },
        {
            "docid": "10155191_10",
            "document": "STAT1 . Gain of function mutation was first discovered in patients with chronic mucocutaneous candidiasis (CMC). This disease is characteristic with its symptoms as persistent infections of the skin, mucosae - oral or genital and nails infections caused by Candida, mostly Candida albicans. CMC may very often result from primary immunodeficiency. Patients with CMC often suffer also with bacterial infections (mostly Staphylococcus aureus), also with infections of the respiratory system and skin. In these patients we can also find viral infections caused mostly by Herpesviridae, that also affect the skin. The mycobacterial infections are often caused by Mycobacterium tuberculosis or environmental bacteria. Very common are also autoimmune symptoms like type 1 diabetes, cytopenia, regression of the thymus or systemic lupus erythematosus. When T-cell deficient, these autoimmune d\u00edseases are very common. CMC was also reported as a common symptom in patients with hyper immunoglobulin E syndrom (hyper-IgE) and with autoimmune polyendocrine syndrome type I. There was reported an interleukin 17A role, because of low levels of IL-17A producing T-cells in CMC patients.",
            "score": 90.99560546875
        },
        {
            "docid": "1171686_14",
            "document": "Regulatory T cell . Studies of human subjects with a history of leishmania infection suggest that modulation of CD8 suppressor T cells is, at least partly, mediated by cytokines. Leishmania specific CD4 helper T cells predominate in adults with strong protective immunity (skin-test positive with no history of clinical infection). When added to autologous leishmania infected macrophages these T cells cause parasite death and secretion of large amounts of interferon-gamma and lymphotoxin. CD8 T suppressor cells predominate in patients with no protective immunity (visceral leishmaniasis patients). When added to autologous peripheral blood mononuclear cells isolated after successful treatment, these T cells inhibit interferon-gamma secretion and proliferation and increase interleukin-6 and interleukin-10 secretion. A soluble factor(s) generated by antigen or phytohemagglutinin stimulation of leishmania-specific CD4 helper T cells from skin-test positive adults killed CD8 T cells but not CD4 helper T cells when added to culture media. Soluble factors generated by antigen stimulation of peripheral blood mononuclear cells from skin-test positive adults prevented CD8 suppressor T cell mediated increases in interleukin-10 secretion. These findings suggest that antigen stimulation of CD4 helper T cells results in production of cytokines that kill or down regulate CD8 T suppressor cells. Once the leishmania infection has been eliminated and leishmania antigens are gone, CD8 T suppressor cells down-regulate CD4 T helper cells. Isolation of cytokines that inhibit and kill CD8 T suppressor cells might be useful in treating diseases that involve immune suppression such as leishmaniasis, AIDS, and certain cancers.",
            "score": 90.42310333251953
        },
        {
            "docid": "1250090_4",
            "document": "Blood culture . When a patient shows signs or symptoms of a systemic infection, results from a blood culture can verify that an infection is present, and they can identify the type (or types) of microorganism that is responsible for the infection. For example, blood tests can identify the causative organisms in severe pneumonia, puerperal fever, pelvic inflammatory disease, neonatal epiglottitis, sepsis, and fever of unknown origin (FUO). However, negative growths do not exclude infection.",
            "score": 89.78567504882812
        },
        {
            "docid": "10330881_7",
            "document": "Pseudomonas oryzihabitans . Symptoms of an infection of \"P. oryzihabitans\" are actually quite vague and similar to the signs that can indicate other illnesses or diseases, so it is relatively difficult to identify when only looking at symptoms. However, in several cases, these infections result after an individual's immune system has been weakened, so it is likely to occur in recovering or ill patients. Most patients, after receiving treatment for another disease or during recovery from surgery, experience chills and increase in body temperature. While these symptoms could mean a variety of things, it is clear that the patient's recovery is halted and that there is an infection of some sort. In an example where a woman developed an infection of \"P. oryzihabitans\" from a case of sinusitis, she experienced the same chills and elevated temperature, but also nasal discharge containing pus, right facial pain, and a fever.",
            "score": 89.11890411376953
        },
        {
            "docid": "2930584_2",
            "document": "Visceral leishmaniasis . Visceral leishmaniasis (VL), also known as kala-azar (), black fever, and Dumdum fever, is the most severe form of leishmaniasis and, without proper diagnosis and treatment, is associated with high fatality. Leishmaniasis is a disease caused by protozoan parasites of the genus \"Leishmania\".",
            "score": 87.81172943115234
        },
        {
            "docid": "34737722_5",
            "document": "Vertebral osteomyelitis . Patients with an advanced case may present some or none of the symptoms associated with general cases of vertebral osteomyelitis. When the osteomyelitis is isolated in the back, as it is in vertebral osteomyelitis, the patient will report muscle spasms coming from the back, but may not report experiencing any fevers. Symptomatic signs vary in each patient and depend on the severity of the case. Neurologic deficiency characterizes advanced, threatening cases of the disease. On average, 40% of patients with an advanced case of vertebral osteomyelitis experience some type of neurological deficiency; this is a sign that the infection has been progressing for some time. In advanced cases, the untreated infection will attack the nervous system through the spinal cord which runs parallel to the vertebral column, placing the patient at risk for paralysis of the extremities. Additionally, loss of the ability to move is a trademark symptom of neurologic problems in advanced cases of vertebral osteomyelitis. Any further signs of neurological deficit signal an advanced case of vertebral osteomyelitis that requires immediate intervention to prevent further threat to the spinal cord.",
            "score": 87.55254364013672
        },
        {
            "docid": "53378240_7",
            "document": "Poonam Salotra . Her research especially covers the development of diagnostic tests and attenuated vaccines, and the study of drug resistance and immune responses in patients suffering from Leishmaniasis, a disease spread by the bite of certain types of sandflies that kills between 20 000 \u2013 50 000 people each year. Dr. Salotra\u2019s focus has been on two of the three main ways that the disease is present \u2013 Visceral Leishmaniasis (VL) and Cutaneous Leishmaniasis.",
            "score": 86.97560119628906
        },
        {
            "docid": "2731676_14",
            "document": "CTLA-4 . Symptomatic patients with CTLA4 mutations are characterized by an immune dysregulation syndrome including extensive T cell infiltration in a number of organs, including the gut, lungs, bone marrow, central nervous system, and kidneys. Most patients have diarrhea or enteropathy. Lymphadenopathy and hepatosplenomegaly are also common, as is autoimmunity. The organs affected by autoimmunity vary but include thrombocytopenia, hemolytic anemia, thyroiditis, type I diabetes, psoriasis, and arthritis. Respiratory infections are also common. Importantly, the clinical presentations and disease courses are variable with some individuals severely affected, whereas others show little manifestation of disease. This \u201cvariable expressivity,\u201d even within the same family, can be striking and may be explained by differences in lifestyle, exposure to pathogens, treatment efficacy, or other genetic modifiers. This condition is described to have incomplete penetrance of disease. Penetrance is said to be incomplete when some individuals fail to express the trait and seem completely asymptomatic, even though they carry the allele. The penetrance is estimated to be about 60%.",
            "score": 86.8551254272461
        },
        {
            "docid": "7038_2",
            "document": "Candidiasis . Candidiasis is a fungal infection due to any type of \"Candida\" (a type of yeast). When it affects the mouth, it is commonly called thrush. Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. Other symptoms may include soreness and problems swallowing. When it affects the vagina, it is commonly called a yeast infection. Signs and symptoms include genital itching, burning, and sometimes a white \"cottage cheese-like\" discharge from the vagina. Yeast infections of the penis are less common and typically present with an itchy rash. Very rarely, yeast infections may become invasive, spreading to other parts of the body. This may result in fevers along with other symptoms depending on the parts involved. More than 20 types of \"Candida\" can cause infection with \"Candida albicans\" being the most common. Infections of the mouth are most common among children less than one month old, the elderly, and those with weak immune systems. Conditions that result in a weak immune system include HIV/AIDS, the medications used after organ transplantation, diabetes, and the use of corticosteroids. Other risks include dentures and following antibiotic therapy. Vaginal infections occur more commonly during pregnancy, in those with weak immune systems, and following antibiotic use. Individuals at risk for invasive candidiasis include low birth weight babies, people recovering from surgery, people admitted to an intensive care units, and those with an otherwise compromised immune systems. Efforts to prevent infections of the mouth include the use of chlorhexidine mouth wash in those with poor immune function and washing out the mouth following the use of inhaled steroids. Little evidence supports probiotics for either prevention or treatment even among those with frequent vaginal infections. For infections of the mouth, treatment with topical clotrimazole or nystatin is usually effective. By mouth or intravenous fluconazole, itraconazole, or amphotericin B may be used if these do not work. A number of topical antifungal medications may be used for vaginal infections including clotrimazole. In those with widespread disease, an echinocandin such as caspofungin or micafungin is used. A number of weeks of intravenous amphotericin B may be used as an alternative. In certain groups at very high risk, antifungal medications may be used preventatively. Infections of the mouth occur in about 6% of babies less than a month old. About 20% of those receiving chemotherapy for cancer and 20% of those with AIDS also develop the disease. About three-quarters of women have at least one yeast infection at some time during their lives. Widespread disease is rare except in those who have risk factors.",
            "score": 86.71583557128906
        },
        {
            "docid": "629684_2",
            "document": "Immunodeficiency . Immunodeficiency (or immune deficiency) is a state in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. Most cases of immunodeficiency are acquired (\"secondary\") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection, extremes of age, and environmental factors, such as nutrition. In the clinical setting, the immunosuppression by some drugs, such as steroids, can be either an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency. A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised person may be particularly vulnerable to opportunistic infections, in addition to normal infections that could affect everyone. Immunodeficiency also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.",
            "score": 86.41895294189453
        },
        {
            "docid": "50033728_5",
            "document": "Cordylobia rodhaini . Myasis is generally defined as the infestation of animal tissue by the larvae of some flies. The larva of myasis-causing flies feed on animal tissue and/or bodily fluids. Myasis caused by the Lund\u2019s fly larvae have presently been reported in Ethiopia, Uganda, Congo, Kenya, Ghana and Cameroon. It is very similar to the myasis that caused by the Tumbu fly, the latter co-existing in the same geographical regions as the Lund's fly. Clinical symptoms start with the formation of a red papule, which is characterized by a small raised swollen area of the skin. These can form on any area of the skin, with the arms, legs, arms and back most frequently affected. Patients typically do not report pain at this stage of infection. The papule enlarges with time, penetrates deep into the skin and develops a central opening, now classified as a furuncle. The central opening facilitates gaseous exchange for the larvae while a serous fluid also exits the same opening. The central opening also makes it possible for the larvae to excrete its fecal matter. At this point, itching and burning sensation are usually described by patients in the affected areas of the skin. Patients also report symptoms such as insomnia (due to pains at night) and fatigue. The disease is usually self-limiting as the larvae drops out, upon reaching the third instar larval stage. Also there have not been any reports of Lund\u2019s fly larvae infestation in systemic areas, such as the internal organs, or blood vessels. The most serious incident of Lund's fly induced myasis reported so far resulted in swelling of the lymph nodes due to adverse immune reactions in the patient. A major distinction between myasis caused by Lund\u2019s fly and myasis caused by other flies is that lesions in Lund\u2019s fly myasis are usually smaller and multiple. Myasis caused by Tumbu fly is, on the other hand, similar to that caused by Lund's fly which is mostly due to the fact that the two flies belong to the same family and might share similar characteristics as a result.",
            "score": 85.84532928466797
        },
        {
            "docid": "36065282_8",
            "document": "Signs and symptoms of HIV/AIDS . People with AIDS also have an increased risk of developing various cancers such as Kaposi's sarcoma, cervical cancer and cancers of the immune system known as lymphomas. Additionally, people with AIDS often have systemic symptoms of infection like fevers, sweats (particularly at night), swollen glands, chills, weakness, and weight loss. The specific opportunistic infections that AIDS patients develop depend in part on the prevalence of these infections in the geographic area in which the patient lives.",
            "score": 84.97206115722656
        },
        {
            "docid": "28583751_3",
            "document": "LIG4 syndrome . As DNA ligase IV is essential in V(D)J recombination, the mechanism by which immunoglobulins, B cell and T cell receptors are formed, patients with LIG4 syndrome may suffer from less effective or defective V(D)J recombination. Some patients have a severe immunodeficiency characterized by pancytopenia, causing chronic respiratory infections and sinusitis. Clinical features also include Seckel syndrome-like facial abnormalities and microcephaly. Patients also suffer from growth retardation and skin conditions, including photosensitivity, psoriasis and telangiectasia. Although not present in all, patients may also present with hypothyroidism and type II diabetes and possibly malignancies such as acute T-cell leukemia. The clinical phenotype of LIG4 syndrome closely resembles that of Nijmegen breakage syndrome (NBS).",
            "score": 84.28324127197266
        },
        {
            "docid": "53827607_2",
            "document": "Leishmania amazonensis . Leishmania amazonesis is a parasite responsible for the disease leishmaniasis. This species has been known to spread by using sandflies as its vector and a vertebrate as its primary host, just like other species of Leishmania. They have also been known to spread throughout the Brazilian Amazon region due to their ecological niches needed for survival and reproduction. However, when the host is infected, the Leishmania can cause 3 different forms of Leishmaniasis. For this species, it has been known to cause cutaneous leishmaniasis and mucocutaneous leishmaniasis. Cutaneous leishmaniasis is commonly characterized with skin lesions, which can appear localized, or throughout the body. While mucocutaneous leishmaniasis is characterized with ulcers around the skin, mouth, and nose. This form of Leishmaniasis has also been known to can spread by metastasis and can be deadly.",
            "score": 84.20001220703125
        },
        {
            "docid": "16031428_7",
            "document": "Heavy chain disease . Patients with Franklin disease usually have a history of progressive weakness, fatigue, intermittent fever, night sweats and weight loss and may present with lymphadenopathy (62%), splenomegaly (52%) or hepatomegaly (37%). The fever is considered secondary to impaired cellular and humoral immunity, and thus recurrent infections are the common clinical presentation in Franklin disease. Weng et al. described the first case of Penicillium sp. infection in a patient with Franklin disease and emphasized the importance of proper preparation for biopsy, complete hematologic investigation, culture preparation and early antifungal coverage to improve the outcome.",
            "score": 84.02307891845703
        },
        {
            "docid": "12999450_19",
            "document": "History of emerging infectious diseases . Cyclospora is a gastrointestinal pathogen that causes fever, diarrhea, vomiting, and severe weight loss. Outbreaks of the disease occurred in Chicago in 1989 and other areas in the United States. But investigation by the Center for Disease Control could not identify an infectious cause. The discovery of the cause was made by Mr. Ramachandran Rajah, the head of a medical clinic's laboratory in Kathmandu, Nepal. Mr. Rajah was trying to discover why local residents and visitors were becoming ill every summer. He identified an unusual looking organism in stool samples from patients who were sick. But when the clinic sent slides of the organism to the Center for Disease Control, it was identified as blue-green algae, which is harmless. Many pathologists had seen the same thing before, but dismissed it as irrelevant to the patient's disease. Later, the organism would be identified as a special kind of parasite, and treatment would be developed to help patients with the infection. In the United States, Cyclospora infection must be reported to the Center for Disease Control according to the CDC's Reportable Disease Chart",
            "score": 83.89381408691406
        },
        {
            "docid": "12738869_11",
            "document": "Leishmania major . Though a vaccine does not yet exist that can prevent cutaneous leishmaniasis, it is speculated that one will be developed in the near future. Patients who have recovered from \"L. major\" infections develop high- level immunity to the pathogen. In Russia and Israel, soldiers were \"immunized\" against \"L. major\" through the injection of live promastigotes into the buttocks; however, this form of treatment was discontinued in Israel due to the occasional formation of large or slow-healing lesions.",
            "score": 83.6100845336914
        },
        {
            "docid": "6983937_3",
            "document": "Primary immunodeficiency . The precise symptoms of a primary immunodeficiency depend on the type of defect. Generally, the symptoms and signs that lead to the diagnosis of an immunodeficiency include recurrent or persistent infections or developmental delay as a result of infection. Particular organ problems (e.g. diseases involving the skin, heart, facial development and skeletal system) may be present in certain conditions. Others predispose to autoimmune disease, where the immune system attacks the body's own tissues, or tumours (sometimes specific forms of cancer, such as lymphoma). The nature of the infections, as well as the additional features, may provide clues as to the exact nature of the immune defect.",
            "score": 83.56196594238281
        },
        {
            "docid": "1399889_4",
            "document": "Lepromin . People who don't have clinical leprosy (Hansen's Disease, or HD) may have little or no skin reaction to the antigen, or may have a strong reaction to it. This is because lepromin only tests for infection, not for ongoing disease. It is believed that most people exposed to \"Mycobacterium leprae\" are not infected and thus would not respond, or are infected but self-resolve or never manifest overt symptoms and therefore would respond to the lepromin skin test. Paradoxically however, patients with \"lepromatous\" (Virchowian) HD, the most severe and transmissible form, have no skin reaction to the antigen. This is because an effective immune response to the bacterium is a result of a cellular immune response (T-cell mediated) rather than a humoral response (B-cell/antibody). Lepromatous HD, the more severe and disfiguring form is a result of the patient's immune response being mainly humoral in nature. Antibodies, the main effectors of a humoral response, are ineffective against \"M. leprae\" because of the unusually dense and waxy nature of the mycolic acid containing bacterial cell wall, and so the bacterium proliferates, causing the cutaneous disfigurements and peripheral neuropathologies characteristic of the disease. The reason there is little or no response to the lepromin test is that a positive response to lepromin is due to \"delayed type hypersensitivity\" which is T-cell mediated, and it is the failure of a robust T-cell response that results in the onset of lepromatous leprosy in the first place. However, given the severe nature of lepromatous leprosy, a skin test is unnecessary, and the definitive test, a biopsy, readily reveals the bacterium within lesions as well as the characteristic histopathology of HD. Moreover, lepromatous HD is typically diagnosed on clinical presentation alone.",
            "score": 83.41238403320312
        },
        {
            "docid": "23730433_4",
            "document": "Joel Weisman . He moved to Los Angeles and was hired by a doctor's office in North Hollywood, where he started to see a number of patients in 1978 who had a series of unusual conditions, including younger men with shingles, a case of Kaposi's sarcoma, and several patients who had symptoms of what appeared to be, but was not, lymphoma. In 1980, a series of patients came to a medical office he had opened in Sherman Oaks, all gay men who had a pattern of what appeared to be immune system disorders exhibited by significant loss of weight and swollen lymph nodes, accompanied by fever and rashes, in addition to two patients with chronic diarrhea, depressed white blood cell counts and fungal infections.",
            "score": 83.3337631225586
        },
        {
            "docid": "52952_3",
            "document": "Adrenoleukodystrophy . In more detail, it is a disorder of peroxisomal fatty acid beta oxidation which results in the accumulation of very long chain fatty acids in tissues throughout the body. The most severely affected tissues are the myelin in the central nervous system, the adrenal cortex, and the Leydig cells in the testes. Clinically, ALD is a heterogeneous disorder, presenting with several distinct phenotypes, and no clear pattern of genotype-phenotype correlation. As an X-linked disorder, ALD presents most commonly in males, however approximately 50% of heterozygote females show some symptoms later in life. Approximately two-thirds of ALD patients will present with the childhood cerebral form of the disease, which is the most severe form. It is characterized by normal development in early childhood, followed by rapid degeneration to a vegetative state. The other forms of ALD vary in terms of onset and clinical severity, ranging from adrenal insufficiency to progressive paraparesis in early adulthood (this form of the disease is typically known as adrenomyeloneuropathy).",
            "score": 83.32731628417969
        },
        {
            "docid": "1580174_5",
            "document": "Morbidity and Mortality Weekly Report . Five cases of \"Pneumocystis carinii\" pneumonia (PCP) were reported in what turned out to be the first reporting of AIDS in the medical literature (June 5, 1981). Los Angeles-based general practitioner Joel Weisman and immunologist Michael S. Gottlieb of the UCLA Medical Center had encountered a series of gay male patients with symptoms that appeared to be immune system disorders including significant loss of weight and swollen lymph nodes, accompanied by fever and rashes, in addition to two patients with chronic diarrhea, depressed white blood cell counts and fungal infections. Gottlieb diagnosed these and a number of his other patients as having pneumocystis pneumonia. A report they jointly wrote and published in the June 5, 1981, issue of \"Morbidity and Mortality Weekly Report\", described their patients as \"5 young men, all active homosexuals, [who] were treated for biopsy-confirmed \"Pneumocystis carinii\" pneumonia at 3 different hospitals in Los Angeles, California\" of which \"[t]wo of the patients died\" by the time of the original report. This notice has been recognized as the first published report marking the official start of the AIDS pandemic and as \"the first report on AIDS in the medical literature\".",
            "score": 83.2386245727539
        },
        {
            "docid": "5650081_5",
            "document": "Hunter syndrome . Hunter syndrome may present with a wide variety of phenotypes. Hunter syndrome has traditionally been categorized as either \"mild\" or \"severe\" depending on the presence of central nervous system symptoms. However, this is an oversimplification. Patients with \"attenuated\" or \"mild\" forms of the disease may still suffer from significant health issues. For severely affected patients, the clinical course is relatively predictable; patients will normally die at an early age. For those with milder forms of the disease, there is a wider variety of outcomes. Many live into their 20s and 30s, but some may have near-normal life expectancies and may even have children. Cardiac and respiratory abnormalities are the usual cause of death for patients with milder forms of the disease.",
            "score": 83.0903549194336
        }
    ]
}